$4000 | Single User
$6000 | Site License
$8000 | Enterprise License

Anti-Infective Drugs Market Global Report 2017
Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)
Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi [Report Updated: 17-07-2017]

Published by The Business Research Company: 17 Jul 2017 | 109257 | In Stock

Introduction

Companies in the anti-infective drugs market are very active with multiple strategic collaborations and agreements. Top companies in the anti-infective drugs market are strategically partnering and collaborating with other companies and government agencies to broaden their products, technologies and services.

The Anti-Infective Drugs Market Global Report provides strategists, marketers and senior management with the critical information they need to assess the global anti-infective drugs sector.


Reasons to Purchase

• Outperform competitors using accurate up to date demand-side dynamics information.

• Identify growth segments for investment.

• Facilitate decision making on the basis of historic and forecast data and the drivers and restraints on the market.

• Create regional and country strategies on the basis of local data and analysis.

• Stay abreast of the latest customer and market research findings

• Benchmark performance against key competitors.

• Develop strategies based on likely future developments.

• Utilize the relationships between key data sets for superior strategizing.

• Suitable for supporting your internal and external presentations with reliable high quality data and analysis

• Gain a global perspective on the development of the market.

• Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the anti-infective drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The anti-infective drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

• The market characteristics section of the report defines and explains the market.

• The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.

• Market segmentations break down market into sub markets.

• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.

• Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.

• The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.

• The anti-infective drugs market section of the report gives context. It compares the anti-infective drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.

• The industry metrics section looks at critical drivers including patient numbers (epidemiology) hospital beds and specialist physicians while the macro-economic section looks at the market in relation to the overall economy.

Scope

Markets Covered: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)

Companies Mentioned: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi

Countries: Brazil, China, France, Germany, India, Italy, Japan, Spain, Russia, UK, USA and Australia.

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East And Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP, Expenditure Per Capita, The Anti-Infective Drugs Indicators Comparison.


Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents
for Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal) Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi [Report Updated: 17-07-2017]

  • 1. Anti-Infective Drugs Market Characteristics;

    2. Anti-Infective Drugs Market Size And Growth;

    2.1. Historic Market Growth; 2.1.1. Drivers Of The Market; 2.1.2. Restraints On The Market; 2.2. Forecast Market Growth; 2.2.1. Drivers Of The Market; 2.2.2. Restraints On The Market;

    3. Pestle Analysis;

    3.1. Political; 3.2. Economic; 3.3. Social; 3.4. Technological; 3.5. Legal; 3.6. Environmental;

    4. Anti-Infective Drugs Market Customer Information;

    5. Anti-Infective Drugs Market Segmentation;

    5.1. Global Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 5.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment; 5.3 Global Anti-Infective Drugs Market Trends And Strategies; 5.3 Global Anti-Infective Drugs Market Trends And Strategies;

    6. Anti-Infective Drugs Market Regional And Country Analysis;

    6.1. Global Anti-Infective Drugs Market, 2016, By Region; 6.2. Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 6.3. Anti-Infective Drugs Market, 2016, By Country; 6.4. Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 6.5. Global Pharmaceutical Market Segments, 2016, By Region; 6.6. Global Pharmaceutical Drugs Market Segments, 2016, By Region; 6.7. Global Pharmaceutical Market Segments, 2016, By Country; 6.8. Global Pharmaceutical Drugs Market Segments, 2016, By Country;

    7. Global Anti-Infective Drugs Market Comparison With Macro Economic Factors;

    7.1. Anti-Infective Drugs Market Size, Percentage Of GDP, Global; 7.2. Per Capita Average Anti-Infective Drugs Expenditure, Global;

    8. Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries;

    8.1. Anti-Infective Drugs Market Size, Percentage Of GDP, By Country; 8.2. Per Capita Average Anti-Infective Drugs Expenditure, By Country;

    9. Anti-Infective Drugs Market Comparison With Industry Metrics;

    9.1. Global Number Of Pharmacists, 2016, By Country; 9.2. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country; 9.3. Global Number Of Pharma Enterprises, 2016, By Country; 9.4. Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country; 9.5. Global Average Spending On R&D/Product Development, 2016, By Country; 9.6. Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country; 9.7. Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.8. Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country; 9.9. Prevalent Cases Of Hiv, 2014, By Country; 9.10. Global Number Of General Practitioners 2016, By Country; 9.11. Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country;

    10. Asia-Pacific Anti-Infective Drugs Market;

    10.1.1. Asia-Pacific Anti-Infective Drugs Market Overview; 10.1.2. Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016; 10.1.3. Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.1.4. Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.2. Asia-Pacific Anti-Infective Drugs Market: Country Analysis; 10.3. China Anti-Infective Drugs Market; 10.3.1. China Anti-Infective Drugs Market Overview; 10.3.2. China Anti-Infective Drugs Historic Market, 2012 - 2016; 10.3.3. China Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.3.4. China Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.3.5. China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.3.6. China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.4. India Anti-Infective Drugs Market; 10.4.1. India Anti-Infective Drugs Market Overview; 10.4.2. India Anti-Infective Drugs Historic Market, 2012 - 2016; 10.4.3. India Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.4.4. India Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.4.5. India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.4.6. India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.5. Japan Anti-Infective Drugs Market; 10.5.1. Japan Anti-Infective Drugs Market Overview; 10.5.2. Japan Anti-Infective Drugs Historic Market, 2012 - 2016; 10.5.3. Japan Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.5.4. Japan Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.5.5. Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.5.6. Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 10.6. Australia Anti-Infective Drugs Market; 10.6.1. Australia Anti-Infective Drugs Historic Market, 2012 - 2016; 10.6.2. Australia Anti-Infective Drugs Forecast Market, 2016 - 2020; 10.6.3. Australia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 10.6.4. Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 10.6.5. Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

    11. Western Europe Anti-Infective Drugs Market;

    11.1.1. Western Europe Anti-Infective Drugs Market Overview; 11.1.2. Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 11.1.3. Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.1.4. Western Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.2. Western Europe Anti-Infective Drugs Market: Country Analysis; 11.3. UK Anti-Infective Drugs Market; 11.3.1. UK Anti-Infective Drugs Market Overview; 11.3.2. UK Anti-Infective Drugs Historic Market, 2012 - 2016; 11.3.3. UK Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.3.4. UK Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.3.5. UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.3.6. UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.4. Germany Anti-Infective Drugs Market; 11.4.1. Germany Anti-Infective Drugs Historic Market, 2012 - 2016; 11.4.2. Germany Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.4.3. Germany Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.4.4 Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.4.5 Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.5 France Anti-Infective Drugs Market; 11.5.1 France Anti-Infective Drugs Historic Market, 2012 - 2016; 11.5.2 France Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.5.3 France Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.5.4 France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.5.5 France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.6. Italy Anti-Infective Drugs Market; 11.6.1. Italy Anti-Infective Drugs Historic Market, 2012 - 2016; 11.6.2. Italy Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.6.3. Italy Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.6.4. Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.6.5. Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020; 11.7. Spain Anti-Infective Drugs Market; 11.7.1. Spain Anti-Infective Drugs Historic Market, 2012 - 2016; 11.7.2. Spain Anti-Infective Drugs Forecast Market, 2016 - 2020; 11.7.3. Spain Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 11.7.4. Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 11.7.5. Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

    12. Eastern Europe Anti-Infective Drugs Market;

    12.1.1. Eastern Europe Anti-Infective Drugs Market Overview; 12.1.2. Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016; 12.1.3. Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.1.4 Eastern Europe Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.2. Eastern Europe Anti-Infective Drugs Market: Country Analysis; 12.3. Russia Anti-Infective Drugs Market; 12.3.1. Russia Anti-Infective Drugs Historic Market, 2012 - 2016; 12.3.2. Russia Anti-Infective Drugs Forecast Market, 2016 - 2020; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; 12.3.3. Russia Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 12.3.4. Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 12.3.5. Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

    13. North America Anti-Infective Drugs Market;

    13.1.1. North America Anti-Infective Drugs Market Overview; 13.1.2. North America Anti-Infective Drugs Historic Market, 2012 - 2016; 13.1.3. North America Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.1.4. North America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.2. North America Anti-Infective Drugs Market: Country Analysis; 13.3. USA Anti-Infective Drugs Market; 13.3.1. USA Anti-Infective Drugs Historic Market, 2012 - 2016; 13.3.2. USA Anti-Infective Drugs Forecast Market, 2016 - 2020; 13.3.3 USA Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 13.3.4. USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 13.3.5. USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

    14. South America Anti-Infective Drugs Market;

    14.1.1. South America Anti-Infective Drugs Market Overview; 14.1.2. South America Anti-Infective Drugs Historic Market, 2012 - 2016; 14.1.3. South America Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.1.4. South America Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.2. South America Anti-Infective Drugs Market: Country Analysis; 14.3. Brazil Anti-Infective Drugs Market; 14.3.1. Brazil Anti-Infective Drugs Historic Market, 2012 - 2016; 14.3.2. Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020; 14.3.3. Brazil Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal); 14.3.4. Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020; 14.3.5. Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020;

    15. Middle East Anti-Infective Drugs Market;

    15.1.1. Middle East Anti-Infective Drugs Market Overview; 15.1.2. Middle East Anti-Infective Drugs Historic Market, 2012 - 2016; 15.1.3. Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020; 15.1.4. Middle East Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);

    16. Africa Anti-Infective Drugs Market;

    16.1.1. Africa Anti-Infective Drugs Market Overview; 16.1.2. Africa Anti-Infective Drugs Historic Market, 2012 - 2016; 16.1.3. Africa Anti-Infective Drugs Forecast Market, 2016 - 2020; 16.1.4. Africa Anti-Infective Drugs Market, 2016, By Segment; Antibiotics; Antivirals; Antifungals; Others (Antihelmethic, Antiprotozoal);

    17. Anti-Infective Drugs Market Competitive Landscape;

    17.1. Company Profiles; 17.2. Pfizer Inc.; 17.2.1. Overview; 17.2.2. Products And Services; 17.2.3. Strategy; 17.2.4. Financial Performance; 17.3. Glaxosmithkline; 17.3.1. Overview; 17.3.2. Products And Services; 17.3.3. Strategy; 17.3.4. Financial Performance; 17.4. F. Hoffmann-La Roche Ltd; 17.4.1. Overview; 17.4.2. Products And Services; 17.4.3. Strategy; 17.4.4. Financial Performance; 17.5. Bristol-Myers Squibb Company; 17.5.1. Overview; 17.5.2. Products And Services; 17.5.4. Financial Performance; 17.6. Sanofi; 17.6.1. Overview; 17.6.2. Products And Services; 17.6.3. Strategy; 17.6.4. Financial Performance;

    18. Key Mergers And Acquisitions In The Anti-Infective Drugs Market;

    19. Market Background: Pharmaceutical Drugs Market;

    19.1.1. Pharmaceutical Drugs Market Characteristics; 19.1.2. Pharmaceutical Drugs Market Historic Growth; 19.1.2.1. Drivers Of The Market; 19.1.2.2. Restraints Of The Market; 19.1.3. Pharmaceutical Drugs Market Forecast Growth; 19.1.3.1. Drivers Of The Market; 19.1.3.2. Restraints Of The Market; 19.1.4. Pharmaceutical Drugs Trends And Strategies; 19.2. Pharmaceutical Drugs Market Regional And Country Analysis; 19.2.1. Global Pharmaceutical Drugs Market, 2016, By Region; 19.2.2. Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region; 19.2.3. Pharmaceutical Drugs Market, 2016, By Country; 19.2.4. Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country; 19.2.5. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment; 19.2.6. Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment; 19.3. Global Pharmaceutical Drugs Market Comparison With Macro Economic Factors; 19.3.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, Global; 19.3.2. Per Capita Average Pharmaceutical Drugs Expenditure, Global; 19.4. Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries; 19.4.1. Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country; 19.4.2. Per Capita Average Pharmaceutical Drugs Expenditure, By Country; 19.5. Key Mergers And Acquisitions In The Pharmaceutical Drugs Market;

    20. Pharmaceuticals Industry Financial Margins;

    21. Appendix;

    21.1. NAICS Definitions Of Industry Covered In This Report; 21.2. Abbreviations; 21.3. Currencies; 21.4. Research Inquiries; 21.5. The Business Research Company; 21.6. Copyright And Disclaimer

List Of Tables
in Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal) Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi [Report Updated: 17-07-2017]

Table 1: Global Anti-Infective Drugs Historic Market Growth

Table 2: Global Anti-Infective Drugs Forecast Market Growth

Table 3: Anti-Infective Drugs Market Segmentation

Table 4: Global Anti-Infective Drugs Market, 2016, By Segment

Table 5: Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment

Table 6: Global Anti-Infective Drugs Market, 2016, By Region

Table 7: Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Table 8: Anti-Infective Drugs Market, 2016, By Country

Table 9: Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Table 10: Global Pharmaceutical Market Segments, 2016, By Region

Table 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Table 12: Global Pharmaceutical Market Segments, 2016, By Country

Table 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Table 14: Anti-Infective Drugs Market Size, Percentage Of GDP, Global

Table 15: Per Capita Average Anti-Infective Drugs Expenditure, Global

Table 16: Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries

Table 17: Anti-Infective Drugs Market Size, Percentage Of GDP, By Country

Table 18: Per Capita Average Anti-Infective Drugs Expenditure, By Country

Table 19: Global Number Of Pharmacists, 2016, By Country

Table 20: Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Table 21: Global Number Of Pharma Enterprises, 2016, By Country

Table 22: Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Table 23: Global Average Spending On R&D/Product Development, 2016, By Country

Table 24: Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Table 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 26: Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Table 27: Prevalent Cases Of Hiv, 2014, By Country

Table 28: Global Number Of General Practitioners 2016, By Country

Table 29: Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Table 30: Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016

Table 31: Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 32: Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment

Table 33: China Anti-Infective Drugs Historic Market, 2012 - 2016

Table 34: China Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 35: China Anti-Infective Drugs Market, 2016, By Segment

Table 36: China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 37: China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 38: India Anti-Infective Drugs Historic Market, 2012 - 2016

Table 39: India Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 40: India Anti-Infective Drugs Market, 2016, By Segment

Table 41: India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 42: India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 43: Japan Anti-Infective Drugs Historic Market, 2012 - 2016

Table 44: Japan Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 45: Japan Anti-Infective Drugs Market, 2016, By Segment

Table 46: Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 47: Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 48: Australia Anti-Infective Drugs Historic Market, 2012 - 2016

Table 49: Australia Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 50: Australia Anti-Infective Drugs Market, 2016, By Segment

Table 51: Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 52: Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 53: Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016

Table 54: Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 55: Western Europe Anti-Infective Drugs Market, 2016, By Segment

Table 56: UK Anti-Infective Drugs Historic Market, 2012 - 2016

Table 57: UK Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 58: UK Anti-Infective Drugs Market, 2016, By Segment

Table 59: UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 60: UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 61: Germany Anti-Infective Drugs Historic Market, 2012 - 2016

Table 62: Germany Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 63: Germany Anti-Infective Drugs Market, 2016, By Segment

Table 64: Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 65: Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 66: France Anti-Infective Drugs Historic Market, 2012 - 2016

Table 67: France Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 68: France Anti-Infective Drugs Market, 2016, By Segment

Table 69: France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 70: France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 71: Italy Anti-Infective Drugs Historic Market, 2012 - 2016

Table 72: Italy Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 73: Italy Anti-Infective Drugs Market, 2016, By Segment

Table 74: Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 75: Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 76: Spain Anti-Infective Drugs Historic Market, 2012 - 2016

Table 77: Spain Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 78: Spain Anti-Infective Drugs Market, 2016, By Segment

Table 79: Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 80: Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 81: Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016

Table 82: Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 83: Eastern Europe Anti-Infective Drugs Market, 2016, By Segment

Table 84: Russia Anti-Infective Drugs Historic Market, 2012 - 2016

Table 85: Russia Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 86: Russia Anti-Infective Drugs Market, 2016, By Segment

Table 87: Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 88: Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 89: North America Anti-Infective Drugs Historic Market, 2012 - 2016

Table 90: North America Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 91: North America Anti-Infective Drugs Market, 2016, By Segment

Table 92: USA Anti-Infective Drugs Historic Market, 2012 - 2016

Table 93: USA Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 94: USA Anti-Infective Drugs Market, 2016, By Segment

Table 95: USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 96: USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 97: South America Anti-Infective Drugs Historic Market, 2012 - 2016

Table 98: South America Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 99: South America Anti-Infective Drugs Market, 2016, By Segment

Table 100: Brazil Anti-Infective Drugs Historic Market, 2012 - 2016

Table 101: Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 102: Brazil Anti-Infective Drugs Market, 2016, By Segment

Table 103: Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Table 104: Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Table 105: Middle East Anti-Infective Drugs Historic Market, 2012 - 2016

Table 106: Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 107: Middle East Anti-Infective Drugs Market, 2016, By Segment

Table 108: Africa Anti-Infective Drugs Historic Market, 2012 - 2016

Table 109: Africa Anti-Infective Drugs Forecast Market, 2016 - 2020

Table 110: Africa Anti-Infective Drugs Market, 2016, By Segment

Table 111: Pfizer Inc. Financial Performance

Table 112: Glaxosmithkline Financial Performance

Table 113: F. Hoffmann-La Roche Ltd Financial Performance

Table 114: Bristol-Myers Squibb Company Financial Performance

Table 115: Sanofi Financial Performance

Table 116: Pharmaceutical Drugs Market Historic Growth

Table 117: Pharmaceutical Drugs Market Forecast Growth

Table 118: Global Pharmaceutical Drugs Market, 2016, By Region

Table 119: Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Table 120: Pharmaceutical Drugs Market, 2016, By Country

Table 121: Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Table 122: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Table 123: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Table 124: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Table 125: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Table 126: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Table 127: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Table 128: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Table 129: Pharmaceuticals Industry Financial Margins

List Of Figures, Charts and Diagrams
in Anti-Infective Drugs Market Global Report 2017 Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal) Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi [Report Updated: 17-07-2017]

Figure 1: Global Anti-Infective Drugs Historic Market Growth

Figure 2: Global Anti-Infective Drugs Forecast Market Growth

Figure 3: Anti-Infective Drugs Market Segmentation

Figure 4: Global Anti-Infective Drugs Market, 2016, By Segment

Figure 5: Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Segment

Figure 6: Global Anti-Infective Drugs Market, 2016, By Region

Figure 7: Global Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Figure 8: Anti-Infective Drugs Market, 2016, By Country

Figure 9: Anti-Infective Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Figure 10: Global Pharmaceutical Market Segments, 2016, By Region

Figure 11: Global Pharmaceutical Drugs Market Segments, 2016, By Region

Figure 12: Global Pharmaceutical Market Segments, 2016, By Country

Figure 13: Global Pharmaceutical Drugs Market Segments, 2016, By Country

Figure 14: Anti-Infective Drugs Market Size, Percentage Of GDP, Global

Figure 15: Per Capita Average Anti-Infective Drugs Expenditure, Global

Figure 16: Anti-Infective Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 17: Anti-Infective Drugs Market Size, Percentage Of GDP, By Country

Figure 18: Per Capita Average Anti-Infective Drugs Expenditure, By Country

Figure 19: Global Number Of Pharmacists, 2016, By Country

Figure 20: Global Anti-Infective Drugs Market Revenue Versus Number Of Pharmacists, 2016, By Country

Figure 21: Global Number Of Pharma Enterprises, 2016, By Country

Figure 22: Global Anti-Infective Drugs Market Revenue Versus Number Of Pharma Enterprises, 2016, By Country

Figure 23: Global Average Spending On R&D/Product Development, 2016, By Country

Figure 24: Global Anti-Infective Drugs Market Revenue Versus Average Spending On R&D/Product Development, 2016, By Country

Figure 25: Global Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 26: Global Anti-Infective Drugs Market Revenue Versus Generic & Branded Sales Proportion By Country (Value), 2016, By Country

Figure 27: Prevalent Cases Of Hiv, 2014, By Country

Figure 28: Global Number Of General Practitioners 2016, By Country

Figure 29: Global Anti-Infective Drugs Market Revenue Versus Number Of General Practitioners, 2016, By Country

Figure 30: Asia-Pacific Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 31: Asia-Pacific Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 32: Asia-Pacific Anti-Infective Drugs Market, 2016, By Segment

Figure 33: China Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 34: China Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 35: China Anti-Infective Drugs Market, 2016, By Segment

Figure 36: China Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 37: China Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 38: India Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 39: India Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 40: India Anti-Infective Drugs Market, 2016, By Segment

Figure 41: India Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 42: India Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 43: Japan Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 44: Japan Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 45: Japan Anti-Infective Drugs Market, 2016, By Segment

Figure 46: Japan Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 47: Japan Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 48: Australia Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 49: Australia Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 50: Australia Anti-Infective Drugs Market, 2016, By Segment

Figure 51: Australia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 52: Australia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 53: Western Europe Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 54: Western Europe Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 55: Western Europe Anti-Infective Drugs Market, 2016, By Segment

Figure 56: UK Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 57: UK Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 58: UK Anti-Infective Drugs Market, 2016, By Segment

Figure 59: UK Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 60: UK Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 61: Germany Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 62: Germany Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 63: Germany Anti-Infective Drugs Market, 2016, By Segment

Figure 64: Germany Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 65: Germany Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 66: France Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 67: France Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 68: France Anti-Infective Drugs Market, 2016, By Segment

Figure 69: France Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 70: France Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 71: Italy Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 72: Italy Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 73: Italy Anti-Infective Drugs Market, 2016, By Segment

Figure 74: Italy Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 75: Italy Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 76: Spain Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 77: Spain Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 78: Spain Anti-Infective Drugs Market, 2016, By Segment

Figure 79: Spain Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 80: Spain Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 81: Eastern Europe Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 82: Eastern Europe Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 83: Eastern Europe Anti-Infective Drugs Market, 2016, By Segment

Figure 84: Russia Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 85: Russia Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 86: Russia Anti-Infective Drugs Market, 2016, By Segment

Figure 87: Russia Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 88: Russia Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 89: North America Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 90: North America Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 91: North America Anti-Infective Drugs Market, 2016, By Segment

Figure 92: USA Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 93: USA Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 94: USA Anti-Infective Drugs Market, 2016, By Segment

Figure 95: USA Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 96: USA Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 97: South America Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 98: South America Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 99: South America Anti-Infective Drugs Market, 2016, By Segment

Figure 100: Brazil Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 101: Brazil Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 102: Brazil Anti-Infective Drugs Market, 2016, By Segment

Figure 103: Brazil Anti-Infective Drugs Percentage Of GDP, 2012 - 2020

Figure 104: Brazil Per Capita Average Anti-Infective Drugs Expenditure, 2012 - 2020

Figure 105: Middle East Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 106: Middle East Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 107: Middle East Anti-Infective Drugs Market, 2016, By Segment

Figure 108: Africa Anti-Infective Drugs Historic Market, 2012 - 2016

Figure 109: Africa Anti-Infective Drugs Forecast Market, 2016 - 2020

Figure 110: Africa Anti-Infective Drugs Market, 2016, By Segment

Figure 111: Pfizer Inc. Financial Performance

Figure 112: Glaxosmithkline Financial Performance

Figure 113: F. Hoffmann-La Roche Ltd Financial Performance

Figure 114: Bristol-Myers Squibb Company Financial Performance

Figure 115: Sanofi Financial Performance

Figure 116: Pharmaceutical Drugs Market Historic Growth

Figure 117: Pharmaceutical Drugs Market Forecast Growth

Figure 118: Global Pharmaceutical Drugs Market, 2016, By Region

Figure 119: Global Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Region

Figure 120: Pharmaceutical Drugs Market, 2016, By Country

Figure 121: Pharmaceutical Drugs Market, 2012 - 2020, Historic And Forecast, By Country

Figure 122: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Segment

Figure 123: Global Pharmaceutical Drugs Market, Growth And Market Share Comparison, By Country And Segment

Figure 124: Pharmaceutical Drugs Market Size, Percentage Of GDP, Global

Figure 125: Per Capita Average Pharmaceutical Drugs Expenditure, Global

Figure 126: Pharmaceutical Drugs Market Comparison With Macro Economic Factors Across Countries

Figure 127: Pharmaceutical Drugs Market Size, Percentage Of GDP, By Country

Figure 128: Per Capita Average Pharmaceutical Drugs Expenditure, By Country

Figure 129: Pharmaceuticals Industry Financial Margins

Additional Details

Publisher

The Business Research Company

Publisher Information

The Business Research Company excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.



The Business Research Company’s Consultants have qualifications from top institutes which include MBAs, MSCs, MDs, CFAs and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.

Reference

109257 | 2098

Number of Pages

125

Report Format

PDF

The Business Research Company Reports

Related Reports

TitleDate PublishedPrice fromMore Details
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies – 2016 Update Humira, Enbrel a...
01 May 2016 by La Merie USD $560 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies – 2016 Update This Competitiv...
01 May 2016 by La Merie USD $335 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies – 2016 UpdateTable of Contents...
01 May 2016 by La Merie USD $335 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 UpdateThis Competitive...
01 May 2016 by La Merie USD $280 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-TNF Antibodies – 2016 Update Humira, Enbrel a...
01 May 2016 by La Merie USD $560 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-Her2 Antibodies – 2016 Update This Competitiv...
01 May 2016 by La Merie USD $335 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies – 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-CD20 Antibodies – 2016 UpdateTable of Contents...
01 May 2016 by La Merie USD $335 More Info
Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 Update
Competitor Analysis: Biosimilar and Biosuperior Anti-EGF-R Antibodies - 2016 UpdateThis Competitive...
01 May 2016 by La Merie USD $280 More Info
Physician Views: Anti-CGRP mAbs looking to shake up migraine prevention – how and where will they fit in?
Scope Drugmakers may finally have cracked the code to developing safe and effective inhibitors of th...
01 May 2015 by FirstWord Pharma USD $695 More Info
Physician Views: What opportunity beyond the anti-TNFs in rheumatoid arthritis?
Scope Last week, FirstWord identified Bayer and Johnson & Johnson's anticoagulant Xarelto as the ind...
18 Mar 2013 by FirstWord Pharma USD $695 More Info

This report is published by The Business Research Company

The Business Research Company excels in company, market and consumer research. It has offices in the UK, the US and India and a network of trained researchers in 15 countries globally.

The Business Research Company’s Consultants have qualifications from top institutes which include MBAs, MSCs, MDs, CFAs and CAs. The Business Research Company’s consultants gain training and qualifications from the Market Research Society and are trained in advanced research practices, techniques, and ethics.

Download Free Report Summary PDF

Anti-Infective Drugs Market Global Report 2017  
Including: Antibiotics, Antivirals, Antifungals, Others (Antihelmethic, Antiprotozoal)
Covering: Pfizer Inc., GlaxosmithKline, F. Hoffmann-La Roche Ltd, Bristol-Myers Squibb Company, and Sanofi [Report Updated: 17-07-2017] | Download PDF Summary

Download our FREE report summary PDF. It contains all the information on these web pages, plus a Proforma Invoice request form, should you need it to satisfy your company's internal order procedures.

Ordering Information

Orders are processed immediately and you will be notified of the despatch date on confirmation of your order.

Accepted Card Types

Payment

Buy now using our secure payment system.

We Stock...

  • Allied Market Research
  • CBR Pharma
  • Current Partnering
  • Firstword
  • Global Data
  • Global Markets Direct
  • ICD Research
  • Infinti Research Technavio
  • Marketline
  • Markets and Markets
  • Micro Markets Monitor
  • MP Advisors
  • Venture Planning Group
  • GMR Data